TORONTO -- A group comprised of doctors, patients, health charities and scientists is urging Ottawa to invest $25 million over the next five years for research into the health effects and potential therapeutic benefits of medical marijuana.
In a report released Wednesday, the Medical Cannabis Research Roundtable highlighted the lack of reliable, peer-reviewed Canadian-based research into marijuana as a potential treatment for a variety of diseases and conditions.
"As our country embarks on a debate about the legalization of recreational marijuana, we should not lose sight of the need to invest in medical science and proper trials to better understand the impacts and effects of medical cannabis," roundtable chairman Dr. Jason McDougall, a professor of pharmacology and anesthesia at Dalhousie University in Halifax, said in a statement.
Read more
Canada Advocate Group Requests More Medical Cannabis Research
Recommended